The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
International comparison of androgen-deprivation therapy (ADT) for the treatment of nonmetastatic (M0) prostate cancer (PC).
Kirsty Hope
Employment or Leadership Position - Adelphi
Research Funding - Amgen
Alex Graham
Employment or Leadership Position - Adelphi
Research Funding - Amgen
Jorge Arellano
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Alexander Liede
Employment or Leadership Position - Amgen
Stock Ownership - Amgen